News Headlines

  1. Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights 8/26/2025

    In a move set to redefine how biotech and biopharma sponsors plan and launch clinical trials, Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies, has partnered with Ryght AI & to bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.

  2. PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research 8/25/2025

    EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants.

  3. CORE 2025 - October 6-8, 2025 8/11/2025

    CORE 2025 brings together leaders across biotech, pharma, regulatory agencies, and digital health to define the future of clinical development, scale innovation into operational excellence, and foster industry-wide alignment.

  4. Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift 8/11/2025

    Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.

  5. ISPOR Champions Research Transparency With Launch Of Open Science Badges 8/4/2025

    ISPOR has introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.

  6. Introducing Arcinova, A Quotient Sciences Company 7/28/2025

    Arcinova offers solutions tailored for early development, from candidate selection through to proof of concept. This means faster, more efficient development pathways, deeper scientific expertise and expanded access to specialized services to help you bring innovative therapies to patients sooner.

  7. November 9-12: ISPOR Europe 2025: Powering Value And Access Through Patient-Centered Collaboration 7/15/2025

    This year’s theme emphasizes the importance of strengthening partnerships across the healthcare ecosystem to accelerate patient-centered decision-making on healthcare value and access.

  8. September 28-30: ISPOR Real-World Evidence Summit 2025: Through The Lens Of Asia Pacific 7/15/2025

    The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

  9. September 10-11: Communicating HEOR For Maximum Impact, Influence, And Understanding 7/15/2025

    Master the art of communicating HEOR evidence to diverse audiences. This course equips participants with tools to communicate their work clearly and effectively, ensuring its relevance and value are understood.

  10. Quotient Sciences Announces Formation Of Scientific Advisory Board 7/15/2025

    Quotient Sciences, a leading integrated CRDMO (contract research, development and manufacturing organization) for the pharmaceutical and biotech industry, is pleased to announce the formation of its Scientific Advisory Board (SAB) and appointment of inaugural members from the US, UK and Europe.